BioSig Technologies Opens Business Office in Norwalk, CT
New Location to Serve as the Company’s East Coast Business and Operations Hub Santa Monica, CA, Oct. 31, 2018 – BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) marketplace, today announced that the Company opened […]
BioSig Technologies Begins Trading on Nasdaq
Santa Monica, CA, Sept. 21, 2018 – BioSig Technologies, Inc. (NASDAQ:BSGM) a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) marketplace, today announced that shares of its common stock have begun officially trading on the Nasdaq Capital Market, under the […]
BioSig Technologies Announces FDA 510(k) Clearance for PURE EP System
Santa Monica, CA, Aug. 14, 2018 – BioSig Technologies, Inc. (OTCQB: BSGM), announced that the Company has received 510(k) clearance for its first product, PURE EP System, from the U.S. Food and Drug Administration (FDA). The non-invasive PURE EP System is a computerized system intended for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording and storing […]
